What Is Therapeutic Apheresis for Loiasis Infection?
At a Glance
Therapeutic apheresis is a blood-filtering procedure used to physically remove microscopic Loa loa parasites. It is required for patients with high parasite counts to safely lower their numbers before taking oral anti-parasite pills, preventing severe and potentially fatal brain complications.
In this answer
4 sections
Therapeutic apheresis (often specifically called leukapheresis) is a specialized medical procedure used to physically filter microscopic Loa loa parasites out of your bloodstream [1][2]. It works much like a dialysis machine: blood is drawn from your body, spun in a centrifuge to separate and remove the layer containing the worms, and then the cleaned blood is returned to you [1][3][4]. This procedure is not a cure on its own, but a crucial preparatory step used exclusively for patients with an extremely high parasite count (known as hyper-infection) to make oral medication safe [1][5].
Why is “Filtering” the Blood Necessary?
When you have Loiasis, the ultimate goal is to clear the infection using anti-parasite medications [2][5]. However, if your parasite count is exceptionally high—typically over 8,000 to 30,000 parasites per milliliter of blood—starting fast-acting medications like diethylcarbamazine (DEC) or ivermectin immediately can be highly dangerous [1][6][2].
If these anti-parasite pills kill too many worms at exactly the same time, the sudden massive die-off releases a flood of parasite material and triggers a severe, system-wide inflammatory reaction [2][7][3]. This intense immune response can damage the blood-brain barrier and lead to Loa loa encephalopathy, a potentially life-threatening complication affecting the brain and nervous system [2][7][6].
To prevent this dangerous reaction, doctors use apheresis as a “debulking” strategy [1][8]. By mechanically pulling a large percentage of the living parasites out of your blood before any fast-acting medication is given, the procedure significantly lowers your risk of serious complications when you do eventually take the pills [1][8][9].
How the Procedure Works
During therapeutic leukapheresis, you will be connected to a specialized apheresis machine:
- The draw: Blood is slowly removed through an intravenous (IV) line in your arm or a specialized catheter (a slightly larger tube) placed in a larger vein in your neck or chest.
- The spin: Inside the machine, your blood is spun rapidly. Because different blood components have different weights, they separate into distinct layers. The microscopic worms (microfilariae) tend to settle in the same layer as your white blood cells (leukocytes) [1][3].
- The removal: The machine extracts the specific layer containing the parasites and white blood cells [1][4]. Do not worry about losing these white blood cells; your immune system constantly produces them and will quickly replace the ones removed during the procedure.
- The return: Your red blood cells, plasma, and remaining fluids are continuously pumped back into your body through another IV line [1][3].
What to Expect: Logistics and Side Effects
Because of the specialized equipment needed, apheresis is typically performed in a hospital setting, such as a specialized hematology or intensive care unit [5][10].
- Time and Comfort: The process usually takes several hours. You will be seated in a comfortable clinical chair or lying in a bed. You can usually read, watch TV, or use your smartphone with your free hand. You may want to bring a blanket, as the filtered blood returning to your body is slightly cooler than your body temperature and can make you feel chilly.
- Multiple Sessions: Depending on how high your initial parasite count is, you might need more than one session to safely drop the numbers into the safe zone for oral treatment [5][10].
- Common Side Effects: The most common side effect is a tingling sensation around your mouth or in your fingers. This happens because the machine uses an anticoagulant (citrate) to keep your blood from clotting inside the tubing, which temporarily lowers your blood calcium levels. Your medical team will monitor you closely and provide calcium replacements (often as chewable tablets or through your IV) to quickly stop the tingling. You might also feel fatigued afterward.
Moving Forward to Treatment
Once the apheresis procedure successfully reduces your parasite levels below the danger threshold, your medical team will carefully initiate standard oral anti-parasitic therapy, often within a few days [1][8]. Because your body will only be dealing with a fraction of the original parasite load, the medications can effectively eliminate the remaining infection with a significantly lower risk of severe side effects [1][8].
Common questions in this guide
Why do I need therapeutic apheresis for Loiasis?
How does the leukapheresis procedure work for Loa loa?
How long does an apheresis session take?
What are the side effects of therapeutic apheresis?
What happens after my blood is filtered for Loiasis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my exact microfilarial count (number of parasites per milliliter of blood), and what is the target number we need to reach with apheresis?
- 2.How many apheresis sessions do you estimate I will need to safely start oral medications?
- 3.Will the procedure be performed using standard IV lines in my arms, or will I need a central catheter placed in a larger vein?
- 4.Which specific fast-acting oral medication (like diethylcarbamazine or ivermectin) is planned after the apheresis, and how soon will it begin?
- 5.How will my care team monitor me for signs of an inflammatory reaction or encephalopathy once the oral medication begins?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (10)
- 1
Safety and effectiveness of apheresis in the treatment of infectious diseases: A systematic review.
Odedra A, Lalloo DG, Kennedy G, et al.
The Journal of infection 2019; (79(6)):513-520 doi:10.1016/j.jinf.2019.09.014.
PMID: 31622632 - 2
Albendazole-related Loa Loa encephalopathy.
Métais A, Michalak S, Rousseau A
IDCases 2021; (23()):e01033 doi:10.1016/j.idcr.2020.e01033.
PMID: 33489754 - 3
Encephalopathy in a patient with loiasis treated with albendazole: A case report.
Volpicelli L, De Angelis M, Morano A, et al.
Parasitology international 2020; (75()):102006 doi:10.1016/j.parint.2019.102006.
PMID: 31676328 - 4
Parasitological, Hematological and Biochemical Characteristics of a Model of Hyper-microfilariaemic Loiasis (Loa loa) in the Baboon (Papio anubis).
Wanji S, Eyong EE, Tendongfor N, et al.
PLoS neglected tropical diseases 2015; (9(11)):e0004202 doi:10.1371/journal.pntd.0004202.
PMID: 26555070 - 5
Imported loiasis: Diagnostic and therapeutic challenges.
Elouardi C, Lefort A, Deconinck L, et al.
Infectious diseases now 2025; (55(3)):105053 doi:10.1016/j.idnow.2025.105053.
PMID: 40064469 - 6
Clinical Features of Imported Loiasis: A Case Series from the Hospital for Tropical Diseases, London.
Saito M, Armstrong M, Boadi S, et al.
The American journal of tropical medicine and hygiene 2015; (93(3)):607-11 doi:10.4269/ajtmh.15-0214.
PMID: 26101271 - 7
Central and Peripheral Nervous System Disorders Following Ivermectin Mass Administration: A Descriptive Study Based on the Democratic Republic of Congo Pharmacovigilance System.
Nzolo D, Anto F, Hailemariam S, et al.
Drugs - real world outcomes 2017; (4(3)):151-158 doi:10.1007/s40801-017-0110-0.
PMID: 28600751 - 8
Therapeutic apheresis using a mononuclear cell program to lower the microfilaria burden of a 23-year-old African woman with loiasis.
Zhao Y, Alexander B, Bailey JA, et al.
Journal of clinical apheresis 2017; (32(3)):200-202 doi:10.1002/jca.21479.
PMID: 27302472 - 9
A novel antigen biomarker for detection of high-level of Loa loa microfilaremia.
Greene SE, Huang Y, Fischer K, et al.
PLoS neglected tropical diseases 2024; (18(9)):e0012461 doi:10.1371/journal.pntd.0012461.
PMID: 39226306 - 10
Delayed-Onset Loiasis: A Case of Loa loa Infection Diagnosed Six Years Post-exposure.
Root HN, Bueno D, Bathurst N, Wieting M
Cureus 2025; (17(6)):e86135 doi:10.7759/cureus.86135.
PMID: 40672032
This page is for informational purposes only and does not replace professional medical advice. Always consult your hematologist or infectious disease specialist regarding therapeutic apheresis and your specific treatment plan.
Get notified when new evidence is published on Loiasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.